Results 1 - 20 of 87 in Sulfasalazine (generic), Azulfidine
-
These diseases are linked by their association with the HLA-B27 gene and by the presence of enthesitis as the basic pathologic lesion.
Comment?
-
Highlights From EULAR 2008, The Annual European Congress Of Rheumatology
Half of patients with early rheumatoid arthritis treated with the anti-tumour necrosis factor inhibitor infliximab plus methotrexate achieve remission, and up to one in five achieve drug-free remission, ...
Comment?
-
RHEUMATOID arthritis is a chronic autoimmune arthritis that can lead to joint deformity and destruction if untreated.
Comment?
-
Rheumatoid Arthritis Treatment Guidelines Updated
New recommendations for the use of disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis have been developed by the American College of Rheumatology.
Comment?
-
Different treatment tactics effective for early RA
Intensive drug regimens for early rheumatoid arthritis appear to substantially control disease progression, whether drugs are introduced using a "stepped-up" method or a more conventional "parallel triple" ...
Comment?
-
What is the evidence for 'devils claw' in arthritis?
What is the evidence for 'devils claw' in arthritis? Answer: Devil's claw is also known as Cat's claw and Uncaria tomentosa.
Comment?
-
How big a risk is rheumatoid factor for Ischaemic heart disease and...
How big a risk is rheumatoid factor for Ischaemic heart disease and at what level should we be treating the cholesterol in patients with rheumatoid arthritis? Answer: A 2007 article in Heart [1] reported the ...
Comment?
-
Long-Term Safety Data On Lialda(TM) (mesalamine) For Patients...
Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Article Date: 19 Jun 2008 - 1:00 PDT Shire Limited , the global specialty biopharmaceutical company, has ...
Comment?
-
Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With...
Long-Term Safety Data on Lialda for Patients With Ulcerative Colitis Published in Leading GI Journal Comtex BASINGSTOKE, UK and PHILADELPHIA, US, Jun 17, 2008 ----Shire Limited , the global specialty ...
Comment?
-
Long-Term Safety Data On Lialda Published In Leading GI Journal
Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials ; Irritable-Bowel Syndrome Article Date: 18 Jun 2008 - 1:00 PDT Shire Limited , the global specialty ...
Comment?
-
New Treatment For Rheumatoid Arthritis Leaves 50 Percent Of Recent...
Results of this study indicate that achieving remission is not only possible during clinical trials but can be a realistic goal of standard clinical care.
Comment?
-
Golimumab Effective In Patients With Active Rheumatoid Arthritis
Findings presented for the first time from a novel, randomized, double-blind, placebo-controlled Phase 3 study showed that patients with moderately-to-severely active rheumatoid arthritis who were previously ...
Comment?
-
The results of a systematic step-up DMARD treatment schedule in combination with tight control At least 50% of recent onset rheumatoid arthritis patients achieve remission within 36 weeks when following a ...
Comment?
-
Encouraging Results Of A Systematic Step-Up DMARD Treatment Schedule For RA Patients
Main Category: Arthritis Also Included In: Clinical Trials / Drug Trials Article Date: 12 Jun 2008 - 6:00 PDT At least 50% of recent onset rheumatoid arthritis patients achieve remission within 36 weeks when ...
Comment?
-
Incyte's JAK Inhibitor Demonstrates Marked Clinical Benefits in Phase IIa Rheumatoid Arthritis Study
Incyte Corporation announced today the presentation of clinical results from a 28-day Phase IIa trial of INCB18424, its orally available janus-associated kinase inhibitor, in patients with rheumatoid arthritis ...
Comment?
-
50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks
The results of a systematic step-up DMARD treatment schedule Paris, France, Wednesday June 11th 2008: At least 50% of recent onset rheumatoid arthritis patients achieve remission within 36 weeks when following ...
Comment?
-
Phase 3 Data Show Efficacy of Golimumab in Patients with Active...
Investigators also reported that the patients who received golimumab showed sustained improvements in disease activity and physical function through six months.
Comment?
-
Recommendations For Rheumatoid Arthritis Therapy Presented By American College Of Rheumatology
Main Category: Arthritis Article Date: 04 Jun 2008 - 4:00 PDT rate article To manage the painful and incapacitating symptoms of rheumatoid arthritis , a chronic, inflammatory joint disease, the majority of ...
Comment?
-
American College of Rheumatology presents recommendations for rheumatoid arthritis therapy
To manage the painful and incapacitating symptoms of rheumatoid arthritis , a chronic, inflammatory joint disease, the majority of patients rely on disease-modifying antirheumatic drugs .
Comment?
-
New research by a team of University of Canberra virologists could offer relief to sufferers of the debilitating arthritis triggered by viral infections like Ross River fever.
Comment?
Sulfasalazine (generic), Azulfidine Forum
Most Popular
